Shigella flexneri Inhibits Intestinal Inflammation by Modulation of Host Sphingosine-1-Phosphate in Mice |
Kim, Young-In
(Laboratory of Microbiology, College of Pharmacy, Ajou University)
Yang, Jin-Young (Mucosal Immunology Laboratory, Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine) Ko, Hyun-Jeong (Laboratory of Microbiology and Immunology, College of Pharmacy, Kangwon National University) Kweon, Mi-Na (Mucosal Immunology Laboratory, Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine) Chang, Sun-Young (Laboratory of Microbiology, College of Pharmacy, Ajou University) |
1 | Ashida, H., M. Ogawa, H. Mimuro, T. Kobayashi, T. Sanada, and C. Sasakawa. 2011. Shigella are versatile mucosal pathogens that circumvent the host innate immune system. Curr. Opin. Immunol. 23: 448-455. DOI ScienceOn |
2 | Shim, D. H., T. Suzuki, S. Y. Chang, S. M. Park, P. J. Sansonetti, C. Sasakawa, and M. N. Kweon. 2007. New animal model of shigellosis in the Guinea pig: its usefulness for protective efficacy studies. J. Immunol. 178: 2476-2482. DOI |
3 | Le Stunff, H., A. Mikami, P. Giussani, J. P. Hobson, P. S. Jolly, S. Milstien, and S. Spiegel. 2004. Role of sphingosine- 1-phosphate phosphatase 1 in epidermal growth factor- induced chemotaxis. J. Biol. Chem. 279: 34290-34297. DOI ScienceOn |
4 | Spiegel, S. and S. Milstien. 2011. The outs and the ins of sphingosine-1-phosphate in immunity. Nat. Rev. Immunol. 11: 403-415. DOI ScienceOn |
5 | Ashida, H., M. Ogawa, M. Kim, H. Mimuro, and C. Sasakawa. 2011. Bacteria and host interactions in the gut epithelial barrier. Nat. Chem. Biol. 8: 36-45. DOI ScienceOn |
6 | Sansonetti, P. J. 2006. Shigellosis: an old disease in new clothes? PLoS Med. 3: e354. DOI |
7 | Le Stunff, H., S. Milstien, and S. Spiegel. 2004. Generation and metabolism of bioactive sphingosine-1-phosphate. J. Cell. Biochem. 92: 882-899. DOI ScienceOn |
8 | Chi, H. 2011. Sphingosine-1-phosphate and immune regulation: trafficking and beyond. Trends Pharmacol. Sci. 32: 16-24. DOI ScienceOn |
9 | Alvarez, S. E., K. B. Harikumar, N. C. Hait, J. Allegood, G. M. Strub, E. Y. Kim, M. Maceyka, H. Jiang, C. Luo, T. Kordula, S. Milstien, and S. Spiegel. 2010. Sphingosine-1- phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 465: 1084-1088. DOI ScienceOn |
10 | Teijaro, J. R., K. B. Walsh, S. Cahalan, D. M. Fremgen, E. Roberts, F. Scott, E. Martinborough, R. Peach, M. B. Oldstone, and H. Rosen. 2011. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 146: 980-991. DOI ScienceOn |
11 | Ashida, H., M. Ogawa, H. Mimuro, and C. Sasakawa. 2009. Shigella infection of intestinal epithelium and circumvention of the host innate defense system. Curr. Top. Microbiol. Immunol. 337: 231-255. |
12 | Tran Van Nhieu, G., R. Bourdet-Sicard, G. Dumenil, A. Blocker, and P. J. Sansonetti. 2000. Bacterial signals and cell responses during Shigella entry into epithelial cells. Cell. Microbiol. 2: 187-193. DOI ScienceOn |
13 | Shim, D. H., S. Ryu, and M. N. Kweon. 2010. Defensins play a crucial role in protecting mice against oral Shigella flexneri infection. Biochem. Biophys. Res. Commun. 401: 554-560. DOI ScienceOn |
14 | Ogawa, M., T. Yoshimori, T. Suzuki, H. Sagara, N. Mizushima, and C. Sasakawa. 2005. Escape of intracellular Shigella from autophagy. Science 307: 727-731. DOI ScienceOn |
15 | Ashida, H., H. Mimuro, M. Ogawa, T. Kobayashi, T. Sanada, M. Kim, and C. Sasakawa. 2011. Cell death and infection: a double-edged sword for host and pathogen survival. J. Cell Biol. 195: 931-942. DOI |
16 | Bergsbaken, T., S. L. Fink, and B. T. Cookson. 2009. Pyroptosis: host cell death and inflammation. Nat. Rev. Microbiol. 7: 99-109. DOI ScienceOn |
17 | Sanada, T., M. Kim, H. Mimuro, M. Suzuki, M. Ogawa, A. Oyama, H. Ashida, T. Kobayashi, T. Koyama, S. Nagai, Y. Shibata, J. Gohda, J. Inoue, T. Mizushima, and C. Sasakawa. 2012. The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response. Nature 483: 623-626. DOI ScienceOn |
18 | Ogawa, M., Y. Yoshikawa, T. Kobayashi, H. Mimuro, M. Fukumatsu, K. Kiga, Z. Piao, H. Ashida, M. Yoshida, S. Kakuta, T. Koyama, Y. Goto, T. Nagatake, S. Nagai, H. Kiyono, M. Kawalec, J. M. Reichhart, and C. Sasakawa. 2011. A Tecpr1-dependent selective autophagy pathway targets bacterial pathogens. Cell Host. Microbe. 9: 376-389. |
19 | Chang, S. Y., S. N. Lee, J. Y. Yang, D. W. Kim, J. H. Yoon, H. J. Ko, M. Ogawa, C. Sasakawa, and M. N. Kweon. 2013. Autophagy controls an intrinsic host defense to bacteria by promoting epithelial cell survival: a murine model. PLoS One 8: e81095. DOI ScienceOn |
20 | Yang, J. Y., S. N. Lee, S. Y. Chang, H. J. Ko, S. Ryu, and M. N. Kweon. 2014. A mouse model of shigellosis by intraperitoneal infection. J. Infect. Dis. 209: 203-215. DOI ScienceOn |
21 | Kotloff, K. L., J. P. Winickoff, B. Ivanoff, J. D. Clemens, D. L. Swerdlow, P. J. Sansonetti, G. K. Adak, and M. M. Levine. 1999. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull. World Health Organ. 77: 651-666. |
22 | Ogawa, M., Y. Handa, H. Ashida, M. Suzuki, and C. Sasakawa. 2008. The versatility of Shigella effectors. Nat. Rev. Microbiol. 6: 11-16. DOI ScienceOn |
23 | Kweon, M. N. 2008. Shigellosis: the current status of vaccine development. Curr. Opin. Infect. Dis. 21: 313-318. DOI ScienceOn |
24 | Fernandez, M. I., A. Thuizat, T. Pedron, M. Neutra, A. Phalipon, and P. J. Sansonetti. 2003. A newborn mouse model for the study of intestinal pathogenesis of shigellosis. Cell. Microbiol. 5: 481-491. DOI ScienceOn |